World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
24660
World Ranking
18350
National Ranking
9160

Mark Kidd publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark Kidd sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 384 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mark Kidd D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark Kidd sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mark Kidd is affiliated with Wren Laboratories in the United States and has contributed extensively to research in medicine, particularly focusing on neuroendocrine tumors and related oncological fields. Their work spans multiple subfields including pulmonary and respiratory medicine, oncology, epidemiology, neurology, and cancer research.

Their research predominantly addresses topics such as neuroendocrine tumor research advances, prostate cancer treatment and research, lung cancer research studies, neuroblastoma research and treatments, cancer, lipids, and metabolism, prostate cancer diagnosis and treatment, and molecular biology techniques and applications.

Mark Kidd's frequent publication venues include the Journal of Clinical Oncology, Cancer Research, The Prostate, Current Opinion in Endocrine and Metabolic Research, and Endocrine Abstracts.

Some of the recent papers authored or co-authored by Mark Kidd include:

  • Neuroendocrine Tumor Omic Gene Cluster Analysis Amplifies the Prognostic Accuracy of the NETest, 2020, Neuroendocrinology
  • A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility, 2021, Annals of Oncology
  • Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?, 2021, Gut
  • Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest), 2021, Annals of Surgical Oncology
  • Molecular Genomic Assessment Using a Blood-based mRNA Signature (NETest) is Cost-effective and Predicts Neuroendocrine Tumor Recurrence With 94% Accuracy, 2021, Annals of Surgery

The scientist has collaborated frequently with researchers including Irvin M. Modlin, Ignat Drozdov, Anna Malczewska, Lisa Bodei, and Alexandra Kitz.

Best Publications

  • A 5‐decade analysis of 13,715 carcinoid tumors

    Irvin M. Modlin M.D.;Kevin D. Lye;Mark Kidd

  • Traces of human migrations in Helicobacter pylori populations

    Daniel Falush;Thierry Wirth;Bodo Linz;Jonathan K. Pritchard

  • Current status of gastrointestinal carcinoids.

    Irvin M. Modlin;Mark Kidd;Igor Latich;Michelle N. Zikusoka

  • The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors

    Ben Lawrence;Bjorn I. Gustafsson;Anthony Chan;Bernhard Svejda

  • Neuroendocrine tumor epidemiology: contrasting Norway and North America.

    Oyvind Hauso;Bjorn I. Gustafsson;Bjorn I. Gustafsson;Mark Kidd;Helge L. Waldum

  • Bronchopulmonary neuroendocrine tumors

    Bjorn I. Gustafsson;Bjorn I. Gustafsson;Mark Kidd;Anthony Chan;Max V. Malfertheiner

  • Recommendations for management of patients with neuroendocrine liver metastases

    Andrea Frilling;Irvin M. Modlin;Mark Kidd;Christopher Russell

  • Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours.

    I. M. Modlin;M. Pavel;M. Kidd;B. I. Gustafsson

  • Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease

    Irvin M. Modlin;Bjorn I. Gustafsson;Bjorn I. Gustafsson;Steven F. Moss;Marianne Pavel

  • Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

    Lisa Bodei;Mark Kidd;Giovanni Paganelli;Chiara M. Grana

  • Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set

    David S. Klimstra;Irvin R. Modlin;N. Volkan Adsay;Runjan Chetty

  • A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem?

    Irvin M Modlin;Kevin D Lye;Mark Kidd

  • Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori

    Richard H. Argent;Mark Kidd;Robert J. Owen;Rachael J. Thomas

  • Carcinoid tumors of the stomach

    Irvin M. Modlin;Kevin D. Lye;Mark Kidd

  • Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants

    Mark Kidd;Irvin M. Modlin;Bjorn I. Gustafsson;Ignat Drozdov

  • Neuroendocrine tumors of the diffuse neuroendocrine system.

    Björn I Gustafsson;Mark Kidd;Irvin M Modlin

  • A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress.

    Irvin M. Modlin;Manish C. Champaneria;Anthony K. C. Chan;Mark Kidd

  • An analysis of rare carcinoid tumors: clarifying these clinical conundrums.

    Irvin M. Modlin;Michael D. Shapiro;Mark Kidd

  • The Clinical Relevance of Chromogranin A as a Biomarker for Gastroenteropancreatic Neuroendocrine Tumors

    Ben Lawrence;Bjorn I. Gustafsson;Mark Kidd;Marianne Pavel

  • Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy.

    Karim M. Eltawil;Bjorn I. Gustafsson;Mark Kidd;Irvin M. Modlin

Frequent Co-Authors

Irvin M. Modlin
Irvin M. Modlin Yale University
Laura H. Tang
Laura H. Tang Memorial Sloan Kettering Cancer Center
Eric P. Krenning
Eric P. Krenning Erasmus University Rotterdam
Giovanni Paganelli
Giovanni Paganelli Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Dik J. Kwekkeboom
Dik J. Kwekkeboom Erasmus University Rotterdam
Kjell Öberg
Kjell Öberg Uppsala University
Shrikant Mane
Shrikant Mane Yale University
Lingeng Lu
Lingeng Lu Yale University
Harvey A. Risch
Harvey A. Risch Yale University
Boaz Nadler
Boaz Nadler Weizmann Institute of Science

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Medicine opens doors to a wide range of careers that can be pursued online. For students interested in the organizational side of healthcare, a healthcare administration degree prepares you to manage medical facilities, develop policies, and lead teams across various healthcare settings.

RNs seeking to advance their clinical skills may consider the asn to np pathway. This online bridge program allows nurses to quickly transition from Associate Degree in Nursing to Nurse Practitioner roles, supporting greater autonomy and earning potential.

Those with a passion for nutrition and preventative health should explore an online dietitian degree. This path leads to careers in dietary counseling, nutrition education, and wellness programming—vital roles in both clinical and community settings.

If you are considering leadership in healthcare, cahme accredited online healthcare administration programs ensure a rigorous education that meets industry standards. Graduates often move into management and executive positions within hospitals, clinics, and healthcare systems.

Best Scientists Citing Mark Kidd

Trending Scientists

Recently Published Articles